![Johan Lund](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Johan Lund
Directeur/Membre du Conseil chez
OLIK HLDG
Profil
Johan Lund is the founder of Kynexis Medicine Development AB, where he is currently the Chief Executive Officer since 2018.
He is also the founder of Harden Pharmacy LLC.
Dr. Lund's current positions include Chairman at Aqilion AB since 2018, Chairman at Neogap Therapeutics AB, Director at Genagon Therapeutics AB since 2019, Director at Tcer AB since 2019, Director at Pelago Bioscience AB, and Independent Non-Executive Director at Olink Holding AB since 2020.
Dr. Lund's former positions include Professor & Chairman-Anatomy & Cell at the University of Bergen, Independent Director at LIDDS AB, VP, Head-Immunology & Inflammation at Celgene Corp.
from 2016 to 2017, Chief Scientific Officer & Senior Vice President at Pfizer Inc. from 2012 to 2015, VP-Respiratory & Inflammation Research at AstraZeneca AB, Associate Professor at Karolinska Institutet, and Managing Partner at J Lund & Associates, LLC from 2015 to 2016.
Dr. Lund's education includes undergraduate and doctorate degrees from Karolinska Institutet.
Dr. Lund is also the founder of Harden Pharmacy LLC.
Postes actifs de Johan Lund
| Sociétés | Poste | Début |
|---|---|---|
| OLIK HLDG | Directeur/Membre du Conseil | 01/12/2020 |
Genagon Therapeutics AB
 Genagon Therapeutics AB BiotechnologyHealth Technology Provides scientific and technical research and development services | Directeur/Membre du Conseil | 01/05/2019 |
Kynexis Medicine Development AB | Directeur Général | 01/08/2018 |
Tcer AB | Directeur/Membre du Conseil | 01/06/2019 |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is an active manager which invests companies located in Sweden. The firm follows of life science companies. It provides financing for early-stage capital requirements. | Président | 12/06/2018 |
Neogap Therapeutics AB
 Neogap Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company | Président | - |
Pelago Bioscience AB
 Pelago Bioscience AB Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization that engages in drug discovery and target engagement and target validation through its technology platform | Directeur/Membre du Conseil | - |
Anciens postes connus de Johan Lund
| Sociétés | Poste | Fin |
|---|---|---|
| CELGENE | Corporate Officer/Principal | 01/05/2017 |
J Lund & Associates, LLC | Corporate Officer/Principal | 01/03/2016 |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ | - |
| ░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Johan Lund
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bergen
 University of Bergen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aqilion AB
Aqilion AB Investment ManagersFinance Aqilion AB is an active manager which invests companies located in Sweden. The firm follows of life science companies. It provides financing for early-stage capital requirements. | Finance |
LIDDS AB
 LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Genagon Therapeutics AB
Genagon Therapeutics AB BiotechnologyHealth Technology Provides scientific and technical research and development services | Health Technology |
Tcer AB | |
Pelago Bioscience AB
Pelago Bioscience AB Miscellaneous Commercial ServicesCommercial Services Operates as a contract research organization that engages in drug discovery and target engagement and target validation through its technology platform | Commercial Services |
Olink Holding AB
 Olink Holding AB BiotechnologyHealth Technology Develops proteomics platform | Health Technology |
Kynexis Medicine Development AB | |
J Lund & Associates, LLC | |
Harden Pharmacy LLC | |
Neogap Therapeutics AB
Neogap Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company | Commercial Services |
